Prehabilitation in Geriatric Patients With Colorectal Neoplasia
- Conditions
- Colo-rectal Cancer
- Interventions
- Other: Prehabilitation course
- First Posted Date
- 2023-05-09
- Last Posted Date
- 2023-05-09
- Target Recruit Count
- 25
- Registration Number
- NCT05851235
- Locations
- 🇮🇹
AUSL della Romagna, Ravenna, RA, Italy
Partial Breast Re-irradiation in Women in Women With Locally Recurrent Breast Cancer Previously Treated With Conservative Surgery and Whole Breast Irradiation
- Conditions
- Breast CancerRecurrent
- Interventions
- Radiation: Partial breast re-irradiation
- First Posted Date
- 2023-03-16
- Last Posted Date
- 2023-04-07
- Target Recruit Count
- 68
- Registration Number
- NCT05772390
- Locations
- 🇮🇹
UO Radioterapia, IRST IRCCS, Meldola, Forlì Cesena, Italy
Pembrolizumab and Olaparib Treatment of Extensive Small Cell Lung Cancer (ES-SCLC)
- Conditions
- SCLC,Extensive Stage
- Interventions
- Drug: Pembrolizumab/Olaparib
- First Posted Date
- 2022-11-21
- Last Posted Date
- 2024-12-09
- Target Recruit Count
- 60
- Registration Number
- NCT05623319
- Locations
- 🇮🇹
UO Oncologia Medica, IRST IRCCS, Meldola, Forlì Cesena, Italy
🇮🇹Ospedale San Gerardo - ASST Monza, Monza, Monza e Brianza, Italy
🇮🇹Azienda Ospedaliera Ospedali Riuniti Marche Nord, Pesaro, Pesaro Urbino, Italy
Effects of Nurse-led Telephone Based Service for Early Palliative Care (PALTEL)
- Conditions
- Palliative CareCancer
- Interventions
- Other: Nurse-led telephonic calls
- First Posted Date
- 2022-06-27
- Last Posted Date
- 2022-06-27
- Target Recruit Count
- 140
- Registration Number
- NCT05434208
- Locations
- 🇮🇹
IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST S.r.l., Meldola, Forlì-Cesena, Italy
The Role of WB-MRI in the Evaluation of Prostate Cancer Patients Treated With Lutetium - Prostate Specific Membrane Antigen (Lu-PSMA)
- Conditions
- Metastatic Castration Resistant Prostate Cancer (mCRPC)
- Interventions
- Diagnostic Test: WB-MRI
- First Posted Date
- 2022-01-26
- Last Posted Date
- 2025-04-01
- Target Recruit Count
- 2
- Registration Number
- NCT05208229
- Locations
- 🇮🇹
European Institute of Oncology, Milan, Italy
🇮🇹IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST s.r.l., Meldola, Forlì-Cesena, Italy
Skin Toxicity by Oncological Therapies
- Conditions
- Skin Toxicity
- First Posted Date
- 2021-11-05
- Last Posted Date
- 2025-05-06
- Target Recruit Count
- 334
- Registration Number
- NCT05109858
- Locations
- 🇮🇹
Ospedale "Franz Tappeiner", Merano, Bolzano, Italy
🇮🇹AUSL della Romagna - Ospedale "M. Bufalini", Cesena, Forlì-Cesena, Italy
🇮🇹IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST S.r.l., Meldola, Forlì-Cesena, Italy
InteGRAtive Analysis of TuMor, Microenvironment, ImmunitY and Patient Expectation for Personalized Response Prediction in Gastric Cancer
- Conditions
- Gastric Cancer
- First Posted Date
- 2021-04-13
- Last Posted Date
- 2024-11-21
- Target Recruit Count
- 250
- Registration Number
- NCT04842916
- Locations
- 🇫🇷
Centre Hospitalier Regional et Universitaire (CHRU), Brest, France
🇫🇷INSERM, Faculty of Medicine (UMR1078), Brest, France
🇬🇷1st Department of Propaedeutic Surgery, National & Kapodistrian University of Athens (NKUA), Athens, Greece
Clinical Study Comparing Different Strategies to Increase Adherence to Oral Therapies in Oncohematology
- Conditions
- Hematologic MalignancySolid TumorOral Drug AdministrationCancer
- Interventions
- Device: TreC-OncoOther: Paper diary
- First Posted Date
- 2021-04-01
- Last Posted Date
- 2021-10-28
- Target Recruit Count
- 124
- Registration Number
- NCT04826458
- Locations
- 🇮🇹
Ospedale Civile Santa Chiara di Trento, Trento, Italy
🇮🇹Irst Irccs, Meldola, FC, Italy
Medication Reconciliation in Oncologic Patients
- Conditions
- Medication Reconciliation
- Interventions
- Other: medication reconciliation
- First Posted Date
- 2021-03-12
- Last Posted Date
- 2024-12-09
- Target Recruit Count
- 100
- Registration Number
- NCT04796142
- Locations
- 🇮🇹
Alessandro Passardi, Meldola, FC, Italy
Experimental Study to Evaluate the Impact of 18 Fluoro-PSMA (18F-PSMA) PET / CT in the Management of Patients with Prostate Cancer.
- Conditions
- 18F-PSMAProstate Cancer
- Interventions
- Drug: 18F-PSMA
- First Posted Date
- 2021-03-01
- Last Posted Date
- 2025-01-09
- Target Recruit Count
- 550
- Registration Number
- NCT04775602
- Locations
- 🇮🇹
Irst Irccs, Meldola, FC, Italy